Chemistry and Pharmacology of Delta-8-Tetrahydrocannabinol

Maged S. Abdel-Kader,Mohamed M. Radwan,Ahmed M. Metwaly,Ibrahim H. Eissa,Arno Hazekamp,Mahmoud A. ElSohly
DOI: https://doi.org/10.3390/molecules29061249
IF: 4.6
2024-03-12
Molecules
Abstract:Cannabis sativa is one of the oldest plants utilized by humans for both economic and medical purposes. Although the use of cannabis started millennia ago in the Eastern hemisphere, its use has moved and flourished in the Western nations in more recent centuries. C. sativa is the source of psychoactive cannabinoids that are consumed as recreational drugs worldwide. The C21 aromatic hydrocarbons are restricted in their natural occurrence to cannabis (with a few exceptions). Delta-9-tetrahydrocannabinol (Δ9-THC) is the main psychoactive component in cannabis, with many pharmacological effects and various approved medical applications. However, a wide range of side effects are associated with the use of Δ9-THC, limiting its medical use. In 1966, another psychoactive cannabinoid, Delta-8-tetrahydrocannabinol (Δ8-THC) was isolated from marijuana grown in Maryland but in very low yield. Δ8-THC is gaining increased popularity due to its better stability and easier synthetic manufacturing procedures compared to Δ9-THC. The passing of the U.S. Farm Bill in 2018 led to an increase in the sale of Δ8-THC in the United States. The marketed products contain Δ8-THC from synthetic sources. In this review, methods of extraction, purification, and structure elucidation of Δ8-THC will be presented. The issue of whether Δ8-THC is a natural compound or an artifact will be discussed, and the different strategies for its chemical synthesis will be presented. Δ8-THC of synthetic origin is expected to contain some impurities due to residual amounts of starting materials and reagents, as well as side products of the reactions. The various methods of analysis and detection of impurities present in the marketed products will be discussed. The pharmacological effects of Δ8-THC, including its interaction with CB1 and CB2 cannabinoid receptors in comparison with Δ9-THC, will be reviewed.
chemistry, multidisciplinary,biochemistry & molecular biology
What problem does this paper attempt to address?
The paper aims to explore the chemical properties, pharmacological effects, and market applications of Δ8-Tetrahydrocannabinol (Δ8-THC). Specifically, the paper addresses the following aspects: 1. **Extraction and Purification Methods of Δ8-THC**: The paper provides a detailed introduction to the methods of isolating and purifying Δ8-THC from cannabis plants and discusses whether Δ8-THC is a naturally occurring compound or a byproduct generated artificially. 2. **Chemical Synthesis Pathways of Δ8-THC**: Given the extremely low natural occurrence of Δ8-THC, the paper focuses on the chemical synthesis methods to prepare Δ8-THC, particularly the process of converting cannabidiol (CBD) into Δ8-THC. 3. **Analysis and Detection Techniques for Δ8-THC**: The paper outlines various techniques used to detect Δ8-THC and its metabolites, including High-Performance Liquid Chromatography-Photodiode Array Detection (HPLC-PDA), Liquid Chromatography-Mass Spectrometry (LC-MS), and Gas Chromatography-Mass Spectrometry (GC-MS). 4. **Pharmacological Effects and Receptor Activity of Δ8-THC**: The paper compares the pharmacological effects of Δ8-THC and Δ9-THC, particularly their effects on CB1 and CB2 cannabinoid receptors. 5. **Δ8-THC Products on the Market**: The paper also discusses the sources of Δ8-THC products sold on the market and the potential impurities they may contain, especially the potential safety risks due to lack of regulation. In summary, this paper aims to provide a comprehensive introduction to the chemical properties, pharmacological effects, and market applications of Δ8-THC, offering a reference for scientific research and market regulation.